Depo-Provera 150, Injektionssuspension (150 mg/ml)

7680307740279 CH-30774 Injektionssuspension
Depo-Provera 150, Injektionssuspension (150 mg/ml)
Depo-Provera 150, Injektionssuspension (150 mg/ml)
Depo-Provera 150, Injektionssuspension (150 mg/ml)
1 / 3
google

Article details

Package size
1 x 1 ml
Selling units
1
Measure
Spritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/08/2025
Summary of Product Characteristics
Français
14/08/2025
Summary of Product Characteristics
Italien
14/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.15 MG Substance HBESI
(N/A)
1.35 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
3.42 MG Substance HBESI

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
30774
Drug name
Depo-Provera 150, Injektionssuspension
Galenic form
SUPA
ATC Code
G03AC06
Authorization status
Z
Dispensing category
B
First authorization
03/06/1964
Authorization expiration date
31/12/9999
IT Number
09.02.1.
Domain
Human medicine
Field of application
Parenterales Kontrazeptivum (Dreimonatsspritze)

Package details

Description (FR)
DEPO PROVERA susp inj 150 mg/ml ser us unique 1 ml
Description (DE)
DEPO PROVERA Inj Susp 150 mg/ml Einwegspr 1 ml
Market launch
12/01/1982
Narcotic (BTM)
No

Other package sizes (1)

DEPO PROVERA susp inj 150 mg/3ml flac 3 ml
1 x 3 ml DUR
GTIN: 7680307740194
Not in V1